-+ 0.00%
-+ 0.00%
-+ 0.00%

RHYTHM PHARMACEUTICALS ANNOUNCES MULTIPLE NEW DATA PRESENTATIONS FROM MC4R AGONISTS IN ACQUIRED HYPOTHALAMIC OBESITY (HO), BARDET-BIEDL SYNDROME (BBS) AND PRADER-WILLI SYNDROME (PWS) AT ENDO 2026

Reuters·06/15/2026 20:01:00

Please log in to view news